Investors
Introduction
Helix BioPharma's product development initiatives include its novel LDOS47 new drug product candidate for the treatment of inoperable Locally advanced recurrent. For more information contact Investor Realation or Shareholder Services
TSX:HBP
Latest Presentations
Constating Documents
Artical of Amendment
Helix BioPharma Corp.by-law